330 related articles for article (PubMed ID: 26021964)
1. Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
Pivetta T; Lallai V; Valletta E; Trudu F; Isaia F; Perra D; Pinna E; Pani A
J Inorg Biochem; 2015 Oct; 151():107-14. PubMed ID: 26021964
[TBL] [Abstract][Full Text] [Related]
2. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
[TBL] [Abstract][Full Text] [Related]
3. Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes.
Cadoni E; Valletta E; Caddeo G; Isaia F; Cabiddu MG; Vascellari S; Pivetta T
J Inorg Biochem; 2017 Aug; 173():126-133. PubMed ID: 28511063
[TBL] [Abstract][Full Text] [Related]
4. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
[TBL] [Abstract][Full Text] [Related]
5. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
[TBL] [Abstract][Full Text] [Related]
6. Copper(II) complexes based on tripodal pyrazolyl amines: Synthesis, structure, magnetic properties and anticancer activity.
Massoud SS; Louka FR; Ducharme GT; Fischer RC; Mautner FA; Vančo J; Herchel R; Dvořák Z; Trávníček Z
J Inorg Biochem; 2018 Mar; 180():39-46. PubMed ID: 29232637
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks.
Pivetta T; Isaia F; Trudu F; Pani A; Manca M; Perra D; Amato F; Havel J
Talanta; 2013 Oct; 115():84-93. PubMed ID: 24054565
[TBL] [Abstract][Full Text] [Related]
8. Pyrophosphate-bridged complexes with picomolar toxicity.
Ikotun OF; Higbee EM; Ouellette W; Doyle RP
J Inorg Biochem; 2009 Sep; 103(9):1254-64. PubMed ID: 19666193
[TBL] [Abstract][Full Text] [Related]
9. Isomeric equilibria in aqueous solution involving aromatic ring stacking in the sexternary complexes formed by the quaternary cis-(NH3)2Pt(2'-deoxyguanosine-N7)(dGMP-N7) complex and the binary Cu(2,2'-bipyridine)2+ or Cu(1,10-phenanthroline)2+ complexes (dGMP2- = 2'-deoxyguanosine 5'-monophosphate).
Lüth MS; Song B; Lippert B; Sigel H
Inorg Chem; 2000 Mar; 39(6):1305-10. PubMed ID: 12526424
[TBL] [Abstract][Full Text] [Related]
10. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
11. Copper (II) complexes possessing alkyl-substituted polypyridyl ligands: Structural characterization and in vitro antitumor activity.
Angel NR; Khatib RM; Jenkins J; Smith M; Rubalcava JM; Le BK; Lussier D; Chen ZG; Tham FS; Wilson EH; Eichler JF
J Inorg Biochem; 2017 Jan; 166():12-25. PubMed ID: 27815978
[TBL] [Abstract][Full Text] [Related]
12. Copper(II) Complexes of Phenanthroline and Histidine Containing Ligands: Synthesis, Characterization and Evaluation of their DNA Cleavage and Cytotoxic Activity.
Leite SM; Lima LM; Gama S; Mendes F; Orio M; Bento I; Paulo A; Delgado R; Iranzo O
Inorg Chem; 2016 Nov; 55(22):11801-11814. PubMed ID: 27934321
[TBL] [Abstract][Full Text] [Related]
13. Copper(II) complexes of salicylic acid combining superoxide dismutase mimetic properties with DNA binding and cleaving capabilities display promising chemotherapeutic potential with fast acting in vitro cytotoxicity against cisplatin sensitive and resistant cancer cell lines.
O'Connor M; Kellett A; McCann M; Rosair G; McNamara M; Howe O; Creaven BS; McClean S; Kia AF; O'Shea D; Devereux M
J Med Chem; 2012 Mar; 55(5):1957-68. PubMed ID: 22313179
[TBL] [Abstract][Full Text] [Related]
14. The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
Marverti G; Gozzi G; Lauriola A; Ponterini G; Belluti S; Imbriano C; Costi MP; D'Arca D
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817267
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and mass spectroscopy kinetics of a novel ternary copper(II) complex with cytotoxic activity against cancer cells.
Barceló-Oliver M; García-Raso A; Terrón A; Molins E; Prieto MJ; Moreno V; Martínez J; Lladó V; López I; Gutiérrez A; Escribá PV
J Inorg Biochem; 2007 Apr; 101(4):649-59. PubMed ID: 17292964
[TBL] [Abstract][Full Text] [Related]
16. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
18. Identification of [PtCl2(phen)] binding modes in amyloid-β peptide and the mechanism of aggregation inhibition.
Ma G; Huang F; Pu X; Jia L; Jiang T; Li L; Liu Y
Chemistry; 2011 Oct; 17(41):11657-66. PubMed ID: 21910144
[TBL] [Abstract][Full Text] [Related]
19. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
[TBL] [Abstract][Full Text] [Related]
20. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
